Texas Instruments has done it again — closing Tuesday at $324.89, up 7.5% on the week and now sitting more than 11% above the consensus analyst price target of $290.
The Street is moving fast to close the gap. B of A Securities' Vivek Arya raised his target to $370 and kept his Buy rating on May 26 — the first analyst call that actually clears the current price with room to spare. Seaport Global upgraded the stock outright to Buy on May 22 with a $400 target. Mizuho lifted to $300, still below the stock. The pattern that defined last week's note — unanimous upward revisions, all trailing the share price — has continued, but now one analyst has finally got ahead of where TXN trades. The consensus is still anchored at $290, which means the mean target has been run over by a stock that gained 17% in a single month. Analyst recommendation divergence ranks in the 89th percentile, meaning the Street's positioning relative to its own history remains unusually stretched to the bullish side. The bull case centres on TXN's analog chip dominance and recovering industrial and data centre demand. The bear case flags Automotive exposure — particularly in China — as the soft underbelly, along with concentration risk if hyperscale infrastructure spending cools.
Short interest adds almost nothing to the story this week, and that is itself notable. Short interest fell roughly 13% over the past month and now sits at just 1.75% of the free float, near the lowest levels seen in the data window. Availability is effectively uncapped — over 900 million shares remain available to borrow, and cost to borrow is a negligible 0.53% annualised. There is no squeeze pressure, no borrow tightness, and no evidence of a growing short thesis. The bears who were present in mid-April — when short interest was running at around 18.5 million shares — have steadily reduced exposure into the rally. The ORTEX short score holds at 30.5, a low reading that confirms this is not a heavily contested stock.
Options positioning has turned more bullish than usual. The put/call ratio dropped to 0.82, nearly 1.4 standard deviations below its 20-day average of 0.92. Two weeks ago the PCR was running above 1.0, with more protection being bought than calls. That has reversed sharply. The shift coincides with the stock's acceleration above $300 — traders who were hedging the move are no longer doing so at the same rate. The 52-week low on the PCR is 0.47, so there is room for the sentiment skew to extend further, but the current reading marks a meaningful rotation compared with the cautious tone that prevailed through early May.
Insiders continue to sell. The CFO, Rafael Lizardi, offloaded roughly $14.7 million worth of stock across multiple transactions on May 14. The CEO, Haviv Ilan, sold $5.6 million on May 4. Several SVPs and a director have also sold in recent weeks. The 90-day net value of insider transactions is positive at $81 million — but that figure reflects the scale of vesting-related activity across the company rather than a signal of conviction buying. Every recent transaction on record is a sale. The insider signal has not changed since last week; it has simply become more consistent.
The closest peers have had a strong week alongside TXN. ON Semiconductor gained 16% on the week. NXP Semiconductors rose 14%. Microchip Technology added nearly 6%. The sector-wide bid is clearly real — this is not TXN outperforming on an idiosyncratic story, but rather the whole analog and embedded semiconductor complex moving together. That context matters: if the sector rotation reverses, TXN has limited short-side friction to slow a drawdown.
The next earnings call is scheduled for July 20. With the stock now trading well through most analyst targets, the July print becomes the first genuine test of whether demand recovery in industrial and automotive end markets has the durability the current valuation implies.
See the live data behind this article on ORTEX.
Open TXN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
